Targeting adipose tissue angiogenesis to enhance insulin sensitivity

Diabetologia

Volumn 55, Issue 10, 2012, Pages 2562-2564

  Manneras Holm L ^a   Krook, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adipose tissue; Angiogenesis; Insulin resistance; Rosiglitazone; Thiazolidinediones; Vascularisation

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANGIOGENESIS INHIBITOR; GLITAZONE DERIVATIVE; ROSIGLITAZONE; VASCULOTROPIN;

ADIPOGENESIS; ADIPOSE TISSUE; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; CYTOKINE RELEASE; DIABETES MELLITUS; DRUG TARGETING; ENERGY BALANCE; ENERGY EXPENDITURE; GLUCOSE TOLERANCE; HUMAN; HYPEROXIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; LIPODYSTROPHY; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SPECIFICITY; TREATMENT DURATION;

ADIPOSE TISSUE; CAPILLARIES; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; THIAZOLIDINEDIONES;

EID: 84866068194     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2651-9     Document Type: Note

References (11)

1. Gealekman O, Guseva N, Gurav K, et al (2012) Effect of rosiglitazone on capillary density and angiogenesis in adipose tissue of normoglycemic humans in a randomized controlled trial. Diabetologia
2. Jonker JW, Suh JM, Atkins AR et al (2012) A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis. Nature 485:391-394
3. Cao Y (2010) Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov 9:107-115
4. Goossens GH, Bizzarri A, Venteclef N et al (2011) Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation. Circulation 124:67-76
5. Sun K, Wernstedt Asterholm I, Kusminski CM et al (2012) Dichotomous effects of VEGF-A on adipose tissue dysfunction. Proc Natl Acad Sci U S A 109:5874-5879
6. Gealekman O, Guseva N, Hartigan C et al (2011) Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation 123:186-194
7. Mori Y, Murakawa Y, Okada K et al (1999) Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care 22:908-912 (Pubitemid 29241043)
8. Gealekman O, Burkart A, Chouinard M, Nicoloro SM, Straubhaar J, Corvera S (2008) Enhanced angiogenesis in obesity and in response to PPARγ activators through adipocyte VEGF and ANGPTL4 production. Am J Physiol Endocrinol Metab 295:E1056-E1064
9. Panigrahy D, Singer S, Shen LQ et al (2002) PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J Clin Invest 110:923-932
10. Spencer M, Unal R, Zhu B et al (2011) Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. J Clin Endocrinol Metab 96:E1990-E1998
11. Lemoine AY, Ledoux S, Queguiner I et al (2012) Link between adipose tissue angiogenesis and fat accumulation in severely obese subjects. J Clin Endocrinol Metab 97:E775-E780